PPT-Practical Hematology Transfusion

Wendy Blount DVM Practical Hematology Anemia 101 Blood Loss Anemia Hemolysis NonRegenerative Anemias Transfusion Medicine Polycythemia Bone Marrow Disease Coagulopathy Central IV Lines. Ashutosh Lal, MD. Northern California Thalassemia Center. UCSF Benioff Children’s Hospital Oakland. Thalassemia Syndromes: . Many diagnoses. Oakland Data (n=203). What is the proportion of . non-transfusion-dependent thalassemia. presented by . Dr Azza Serry. Blood transfusion. . Blood . is a precious as the only source is the human being , so handling of the blood should be conducted with the deserved dignity and administered in its proper indication . . Based on the Patient Blood Management Guidelines. Be. . SINGLE . m. inded. Patient Blood Management Guidelines. www.blood.gov.au. . Single Unit. Transfusion Guideline. WHO . The stable, normovolaemic inpatient who . Lyle R. Petersen, MD, MPH. Brad Biggerstaff, PhD. Division of Vector-Borne Diseases. Centers for Disease Control and Prevention. Blood Products Advisory Committee Meeting. December 14, 2010. Agenda. Arbovirus risk model. Targeted Cancer Therapies. Dr . Ongóndi. .M. KNH-Dept. Internal Medicine. Hemato. -Oncology. Objectives. Traditional chemotherapy. Targeted chemotherapy. Country status. Challenge !!!. Administer sufficiently high dose of . Maria Proytcheva, MD. University of Arizona. Banner University Medical Center-Tucson, USA. Financial Disclosure. The author has no conflict of interest to disclose. Do the Current Practices of Developing Neonatal Reference Intervals Meet Clinical Need?. Reduce Complications of . Prematurity. . A . Multi-site Quality Improvement Project. Sponsored . by the Indiana State Department of . Health. . Presenter: Sandra Hoesli, MD, MS. Objectives. Describe the Indiana Vermont Oxford Network Quality Collaborative (. Dr. Soheila . zareifar. Department of pediatric hematology/oncology. Shiraz university of medical sciences. Qeshm. 2018. Transfusion in Sickle Cell. In sickle cell disease transfusions improve blood flow by reducing the proportion of red cells capable of forming sickle hemoglobin polymer. . Outline. Anemia. Thrombocytopenia. Neutropenia. Coagulation disorders. Lymphoma. Terese. Winslow, Lydia . Kibiuk. , http://. stemcells.nih.gov. /info/. scireport. /pages/chapter5.aspx. Terese. Winslow, Lydia . below is notmprehensive list it is representative of some common Blood FractionsexamplesInitial only those that you or the patientwill acceptProduct/Treatment Involving the Use of One146s Own Blood C , RN. Evy Warmbier, MSN, RN, CNE. Objectives. To Identify the Basic Hematological Components. To Understand the Clotting Cascade. To Relate the Fibrinolytic Systems Regarding Medication Administration. Alice J. Cohen, M.D., F.A.C.P.. Newark Beth Israel Medical Center. Associate Clinical Professor of Medicine. Rutgers - New Jersey Medical School. Newark, NJ. Disclosures. None. Scope of the Problem. Barbara A. Konkle, M.D.. Medical Director, Hemostasis Reference Laboratory. Puget Sound Blood Center. Professor of Medicine/Hematology. University of Washington. Seattle, WA. Disclosures. Nothing to disclose. Infusion of . blood products . for the purpose of restoring circulating volume.. Administration . of blood and blood components requires knowledge of correct administration techniques and possible complications.